NUTRILIPID 20% Drug Patent Profile
✉ Email this page to a colleague
When do Nutrilipid 20% patents expire, and when can generic versions of Nutrilipid 20% launch?
Nutrilipid 20% is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in NUTRILIPID 20% is soybean oil. There are thirteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the soybean oil profile page.
Summary for NUTRILIPID 20%
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NUTRILIPID 20% at DailyMed |
Pharmacology for NUTRILIPID 20%
Drug Class | Lipid Emulsion |
Anatomical Therapeutic Chemical (ATC) Classes for NUTRILIPID 20%
US Patents and Regulatory Information for NUTRILIPID 20%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B Braun | NUTRILIPID 20% | soybean oil | INJECTABLE;INJECTION | 019531-002 | May 28, 1993 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |